Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN360345 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 3 (RPS6KA3) (N-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region of human RSK3.
- Description
- Protein A column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- N-Term
- Vial size
- 0.4 mL
- Concentration
- 0.25 mg/mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at-20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Delineation of the mechanisms of aberrant splicing caused by two unusual intronic mutations in the RSK2 gene involved in Coffin-Lowry syndrome.
Expression of the RSK2 gene during early human development.
ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome.
RSK2 activity is regulated by its interaction with PEA-15.
Ataxia telangiectasia mutated proteins, MAPKs, and RSK2 are involved in the phosphorylation of STAT3.
Zeniou M, Gattoni R, Hanauer A, Stévenin J
Nucleic acids research 2004;32(3):1214-23
Nucleic acids research 2004;32(3):1214-23
Expression of the RSK2 gene during early human development.
Guimiot F, Delezoide AL, Hanauer A, Simonneau M
Gene expression patterns : GEP 2004 Jan;4(1):111-4
Gene expression patterns : GEP 2004 Jan;4(1):111-4
ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome.
Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, Schinke T, Li L, Brancorsini S, Sassone-Corsi P, Townes TM, Hanauer A, Karsenty G
Cell 2004 Apr 30;117(3):387-98
Cell 2004 Apr 30;117(3):387-98
RSK2 activity is regulated by its interaction with PEA-15.
Vaidyanathan H, Ramos JW
The Journal of biological chemistry 2003 Aug 22;278(34):32367-72
The Journal of biological chemistry 2003 Aug 22;278(34):32367-72
Ataxia telangiectasia mutated proteins, MAPKs, and RSK2 are involved in the phosphorylation of STAT3.
Zhang Y, Cho YY, Petersen BL, Bode AM, Zhu F, Dong Z
The Journal of biological chemistry 2003 Apr 11;278(15):12650-9
The Journal of biological chemistry 2003 Apr 11;278(15):12650-9
No comments: Submit comment
No validations: Submit validation data